Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 261

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 261
---
As will increase their CLA and up to an additional aggregate amount of $450. According to the October
2024 Addendum, the 2020 CLAs of the non-participating Lenders shall bear interest at 8% per annum until maturity commencing as of July
1, 2024, and of the 2020 CLA of the participating Lenders commencing as of March 31, 2025. In addition, pursuant the October 2024 Addendum,
upon the earlier of March 31, 2025 or occurrence of an IPO, the CLA 2020 principal and accrued interest will be automatically converted
into 243,955 ordinary shares based on a pre money valuation of $5,150. In addition, the Company will pay to the Participating Lender an
amount of $340 as a risk premium, which will be automatically converted in the same terms as above into 221,456 Ordinary Shares of the
Company. As of March 5, 2025, the Company received $450 out of the $450 proceeds.

Between October 2024 and November 2024,
the Company entered into the October 2024 bridge loan agreements (the “Bridge Loans”), pursuant to which the Company obtained
a bridge loan from the lenders thereto including certain related parties (the “Bridge Loan Lenders”). The Bridge Loans will
be repaid at the earlier of consummation of an IPO or on March 31, 2025 (the “Bridge Loans Maturity Date”) and shall bear
interest at 8% per annum until maturity commencing as of September 1, 2024. In addition, at the Bridge Loans Maturity Date, the Company
shall pay the Bridge Loan Lenders, on a pro rata basis to each Bridge Loan Lender participation to the loan amount, an aggregate risk
premium equal to 30% of the loan amount. Furthermore, upon the occurrence of an IPO for a toral offering of not less than $6,000, the
Bridge Loan Lenders, shall be granted warrants to purchase such number of ordinary shares equal to two times the loan amount based on
a price per share equal to 75% of the lowest price per share of the Company’s ordinary shares, during the first five trading days
from the consummation of an IPO. As of March 5, 2025, the Company raised $350 under such Bridge Loans.

In December 2024, the Company entered into a